Daewoong Pharmaceutical Hosts Summit for Key Global KOLs in Bali

"35 Key KOLs from 11 Countries Carefully Selected and Invited"
Operating a Top-Tier Education Program Distinct from NMC

Daewoong Pharmaceutical said on November 3 that it held the premium academic event “NMC EXCLUSIVE Global KOL Summit Bali 2026” in Bali, Indonesia, from October 29 to 31 (local time), inviting key opinion leaders (KOLs) from around the world.

The Nabota Master Class (NMC) is Daewoong Pharmaceutical's flagship education program, designed to strengthen the clinical capabilities of medical professionals worldwide and promote academic exchange. NMC EXCLUSIVE is its top-tier education program, distinguished by its invitation of key KOLs with extensive clinical experience with Nabota and influence in their respective countries.

A view of the venue for Daewoong Pharmaceutical's NMC EXCLUSIVE Global KOL Summit Bali 2026. Daewoong Pharmaceutical.

While the existing NMC focuses on strengthening the clinical capabilities of medical professionals worldwide, NMC EXCLUSIVE is a differentiated program in which highly specialized KOLs share advanced clinical knowledge and experience with complex procedures, and discuss the future direction of Nabota's clinical development.

The event was attended by 35 key medical professionals from 11 countries, including Korea and countries in the Asia-Pacific, Middle East, and Latin America.

“This NMC EXCLUSIVE was significant because we invited key global KOLs at the forefront of Nabota's clinical use and provided education at a higher level, along with in-depth academic discussions,” said Yoon Junsu, head of Daewoong Pharmaceutical's Nabota Business Division. “We will continue to enhance medical professionals' expertise through differentiated education programs and work to help Daewoong Pharmaceutical become a key player in the global aesthetics market.”

This content was produced with the assistance of AI translation services.